BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kaiser K, Lyleroehr M, Shaunfield S, Lacson L, Corona M, Kircher S, Nittve M, Cella D. Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale. World J Gastrointest Oncol 2020; 12(2): 205-218 [PMID: 32104551 DOI: 10.4251/wjgo.v12.i2.205]
URL: https://www.wjgnet.com/1948-5204/full/v12/i2/205.htm
Number Citing Articles
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, Farid Hashemi, Fardin Hashemi, Saeed Samarghandian, Masoud Najafi. MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancerLife Sciences 2020; 256: 117973 doi: 10.1016/j.lfs.2020.117973
Chien-Chen Huang, Tsung-Jung Ho, Hsin-Yueh Ho, Pei-Yu Chen, Cheng-Hao Tu, Yu-Chuen Huang, Yu-Chen Lee, Mao-Feng Sun, Yi-Hung Chen. Acupuncture Relieved Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast Cancer: A Pilot Randomized Sham-Controlled TrialJournal of Clinical Medicine 2021; 10(16): 3694 doi: 10.3390/jcm10163694
Tomislav Vlaski, Marija Slavic, Reiner Caspari, Bettine Bilsing, Harald Fischer, Hermann Brenner, Ben Schöttker. From a Clustering of Adverse Symptoms after Colorectal Cancer Therapy to Chronic Fatigue and Low Ability to Work: A Cohort Study Analysis with 3 Months of Follow-UpCancers 2024; 16(1): 202 doi: 10.3390/cancers16010202
Mohammad Alsalem, Amr Ellaithy, Sarah Bloukh, Mansour Haddad, Tareq Saleh. Targeting therapy-induced senescence as a novel strategy to combat chemotherapy-induced peripheral neuropathySupportive Care in Cancer 2024; 32(1) doi: 10.1007/s00520-023-08287-0
Jamie Burgess, Maryam Ferdousi, David Gosal, Cheng Boon, Kohei Matsumoto, Anne Marshall, Tony Mak, Andrew Marshall, Bernhard Frank, Rayaz A. Malik, Uazman Alam. Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and TreatmentOncology and Therapy 2021; 9(2): 385 doi: 10.1007/s40487-021-00168-y
Lili Lu, Randy Przybylla, Yuru Shang, Meng Dai, Mathias Krohn, Oliver Holger Krämer, Christina Susanne Mullins, Michael Linnebacher. Microsatellite Status and IκBα Expression Levels Predict Sensitivity to Pharmaceutical Curcumin in Colorectal Cancer CellsCancers 2022; 14(4): 1032 doi: 10.3390/cancers14041032
Tiffany Li, Susanna B. Park, Eva Battaglini, Madeleine T. King, Matthew C. Kiernan, David Goldstein, Claudia Rutherford. Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future useQuality of Life Research 2022; 31(11): 3091 doi: 10.1007/s11136-022-03154-7
Housem Kacem, Annamaria Cimini, Michele d’Angelo, Vanessa Castelli. Molecular and Cellular Involvement in CIPNBiomedicines 2024; 12(4): 751 doi: 10.3390/biomedicines12040751
Guoqiong Lei, Sushun Liu, Xin Yang, Chao He, Ravindran Caspa Gokulan. TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer CellCanadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/8870907
Per Pfeiffer, Maryam Lustberg, Jacques Näsström, Stefan Carlsson, Anders Persson, Fumiko Nagahama, Guido Cavaletti, Bengt Glimelius, Kei Muro. Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M)JNCI Cancer Spectrum 2022; 6(6) doi: 10.1093/jncics/pkac075
Seohyuk Lee, Chao Ma, Qian Shi, Pankaj Kumar, Felix Couture, Philip Kuebler, Smitha Krishnamurthi, DeQuincy Lewis, Benjamin Tan, Richard M. Goldberg, Alan Venook, Charles Blanke, Eileen M. O'Reilly, Anthony F. Shields, Jeffrey A. Meyerhardt. Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702Journal of Clinical Oncology 2023; 41(5): 1079 doi: 10.1200/JCO.22.01637